Natural History of Medullary Thyroid Cancer to Inform Advanced Disease Management
Launched by M.D. ANDERSON CANCER CENTER · Jan 2, 2020
Trial Information
Current as of July 01, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying medullary thyroid cancer (MTC), a type of cancer that starts in the thyroid gland and can spread to other parts of the body. The goal of the study is to better understand how this cancer develops and progresses, particularly in more advanced stages. By collecting information from patients, researchers hope to improve how this disease is managed and treated in the future.
To participate in this study, you need to have been diagnosed with medullary thyroid cancer and be part of the Medullary Thyroid Cancer Registry. This includes patients at all stages of the disease, but specifically for one part of the study, you must have advanced MTC. Participants will be asked to share their medical information, which will help researchers learn more about the disease. If you're interested, you can reach out to see if you qualify and what the next steps would be.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Aims 1 and 2: A diagnosis of MTC
- • Aims 1 and 2: A registrant in the Medullary Thyroid Cancer Registry (MTCR). Patients of all disease phases will be eligible for enrollment
- • Aim 3: A diagnosis of advanced phase (red or gray) MTC as determined by clinical team
- • Aim 3: A current registrant in the MTCR
About M.D. Anderson Cancer Center
The University of Texas MD Anderson Cancer Center is a leading institution dedicated to cancer care, research, education, and prevention. As one of the world’s most respected cancer centers, MD Anderson focuses on innovative treatment approaches and groundbreaking clinical trials aimed at improving patient outcomes. With a multidisciplinary team of experts and state-of-the-art facilities, the center is committed to advancing cancer research and providing comprehensive, personalized care to patients. MD Anderson's clinical trials play a pivotal role in translating scientific discoveries into effective therapies, positioning the center at the forefront of cancer treatment and research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Houston, Texas, United States
San Francisco, California, United States
Patients applied
Trial Officials
Elizabeth G Grubbs
Principal Investigator
M.D. Anderson Cancer Center
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials